Indivior logo

INDV - Indivior News Story

147.1p -0.9  -0.6%

Last Trade - 12:11pm

Market Cap £1.09bn
Enterprise Value £615.4m
Revenue £479.7m
Position in Universe 410th / 1827

Indivior PLC - Director Declaration

Wed 11th April, 2018 4:02pm
RNS Number : 6272K
Indivior PLC
11 April 2018
 

Indivior PLC (the 'Company')

 

Indivior PLC confirms that Mr Daniel Tassé, Senior Independent Director, was appointed as an independent director of HLS Therapeutics Inc., a specialty pharmaceutical company listed on the TSX Venture Exchange, with effect from March 14, 2018.

 

This announcement is made in accordance with Listing Rule 9.6.14.

 

Kathryn Hudson

Company Secretary


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNFKDDKPBKDDQD
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.